San Diego, CA, United States of America

Trevor Denbo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Trevor Denbo: Innovator in Diabetes Therapy

Introduction

Trevor Denbo is a notable inventor based in San Diego, CA, who has made significant contributions to diabetes therapy. His innovative approach focuses on integrating continuous glucose monitoring (CGM) data into diabetes management systems. With a keen understanding of the challenges faced by individuals with diabetes, Denbo has developed solutions that enhance the effectiveness of insulin delivery.

Latest Patents

Denbo holds a patent for "Methods of incorporating CGM data into diabetes therapy." This patent discloses apparatuses and methods that incorporate an infusion pump and a CGM. The system includes software designed to automatically populate a blood glucose section of a bolus calculator with the most recent valid CGM value. Additionally, the software can be programmed to populate the bolus calculator with a single CGM reading only when specific predefined conditions are met, thereby mitigating the risk of inaccurate or invalid readings.

Career Highlights

Trevor Denbo is currently employed at Tandem Diabetes Care, Inc., where he continues to innovate in the field of diabetes management. His work is instrumental in developing technologies that improve the quality of life for individuals living with diabetes. Denbo's dedication to research and development has positioned him as a key player in the medical technology industry.

Collaborations

Denbo collaborates with talented professionals in his field, including Michael Michaud and Garrett Marin. These partnerships foster an environment of creativity and innovation, leading to advancements in diabetes care technologies.

Conclusion

Trevor Denbo's contributions to diabetes therapy through his innovative patent and work at Tandem Diabetes Care, Inc. highlight his commitment to improving patient outcomes. His efforts in integrating CGM data into therapy represent a significant advancement in diabetes management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…